Loncastuximab tesirine

loncastuximab tesirine · ADC Therapeutics S.A.

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for Loncastuximab tesirine, covering 2021-07-29 to 2026-04-28. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Phase 3]

See pricing